CONCORDBIO
NSEConcord Biotech Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,304.70
0.70 (0.05%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹13.65K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
53.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹987+32.2%
52W High₹1,980-34.1%
Current Price
₹1,304.70
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,043.76
Upper Circuit₹1,565.64
Reference Price
₹1,304.70
Investment Checklist
Bear Flag on 1D — target ₹1232.1
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Fundamental score 36 — moderate financial health
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
41%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
1281.43
EMA50
1234.98
EMA200
1324.67
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹1314.90
₹1334.20
₹1382.45
₹1407.90
₹1425.20
Support (Below)
₹1291.30
₹1255.80
₹1234.20
₹1113.60
₹1097.87
Volume Analysis
TrendDECREASING
Change-46.80%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹1291.65
3% Risk₹1265.56
5% Risk₹1239.46
7% Risk (Custom)
₹1213.37Technical Levels
1x ATR (Volatility)₹1257.19
2x ATR (Swing)₹1209.68
3x ATR (Trend)₹1162.17
Immediate Support₹1291.30
Moving Averages
EMA 9 (Short-term)₹1288.91
EMA 20 (Medium-term)₹1281.43
EMA 50 (Trend)₹1234.98
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹409.6 Cr | ₹204 Cr | ₹247.1 Cr | ₹277.8 Cr |
| Net Profit | ₹140.4 Cr | ₹44.1 Cr | ₹63.1 Cr | ₹63.6 Cr |
| EPS | — | ₹4.21 | ₹6.03 | ₹6.08 |
| Operating Profit | ₹198.3 Cr | ₹76.6 Cr | ₹104.1 Cr | ₹105 Cr |
ROE
20.50%
ROCE
27.27%
Debt/Equity
0.00
Current Ratio
6.17
OPM
37.80%
NPM
22.91%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Concord Biotech Limited | ₹1,304.70 | -0.05% | 53.3 | ₹13.65K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 03 Sept 2025 | Dividend - Rs 10.70 Per Share | DIVIDEND |
| 21 Jun 2024 | Dividend - Rs 8.75 Per Share | DIVIDEND |
| 21 Jun 2024 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CONCORDBIO
View AllNEWS
positive
Business Standard - Markets 16d ago
Concord Biotech's formulation facility clears regulatory inspections by Kenya's PPB & Uganda's NDA
Concord Biotech has announced the successful completion of inspection of the company's Unit-II formulation facility by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda.
CONCORDBIOHealthcare
positive
NDTV Profit 16d ago
Stock Picks Today: SBI, HDFC AMC, Nestle, Hero Moto, Kajaria, Syngene, Concord Biotech, And More On Brokerages' Radar
Brokerages' Radar
CONCORDBIONESTLEINDSYNGENEFast Moving Consumer GoodsHealthcare
NEWS
positive
Business Standard - Markets 28d ago
Concord Biotech completes ANVISA inspection at Limbasi API facility
Concord Biotech announced the successful completion of an inspection conducted by Brazil's National Health Surveillance Agency (ANVISA) at its active pharmaceutical ingredient (API) manufacturing facility in Limbasi.
CONCORDBIOMEDANTAHealthcare